Ryzneuta

Medicinal product

(Invented) name

Ryzneuta

Active substance (s)

Efbemalenograstimas alfa

Strength

20 mg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L03AA18, efbemalenograstim alfa

Marketing authorisation holder

Evive Biotechnology Ireland Ltd., Airija

Date of authorisation

2024-03-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Kiekviename užpildytame švirkšte yra	1 ml
Efbemalenograstimas alfa	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113244	99363	1099363	užpildytas švirkštas	N1		Receptinis	EU/1/24/1793/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-03-21	Registruotas